—
Price
—
Market Cap
—
P/E Ratio
—
Forward P/E
—
EPS (TTM)
—
Dividend Yield
—
Cash
—
Total Debt
—
Shares Out
Institutional Ownership of Atara Biotherapeutics Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Atara Biotherapeutics Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2023-Q4 | |||||
| SELL | EXIT | — | — | — | |
| 2023-Q2 | |||||
| BUY | +7.1% | 9.8M | $16M | — | |
| 2023-Q1 | |||||
| BUY | +12.3% | 9.1M | $26M | — | |
| 2022-Q1 | |||||
| SELL | -4.2% | 8.1M | $75M | — | |
| 2021-Q1 | |||||
| SELL | -6.9% | 8.5M | $122M | — | |
| 2020-Q4 | |||||
| SELL | -8.2% | 9.1M | $179M | — | |
| 2020-Q2 | |||||
| BUY | +19.4% | 9.9M | $145M | — | |
| 2019-Q3 | |||||
| BUY | +18.7% | 8.3M | $117M | — | |
| 2019-Q2 | |||||
| BUY | +9.7% | 7.0M | $141M | — | |
| 2019-Q1 | |||||
| BUY | +2.0% | 6.4M | $254M | — | |
| 2018-Q1 | |||||
| BUY | +16.7% | 6.3M | $244M | — | |
Insider Trading for Atara Biotherapeutics Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.